Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

The complexity of the adherence-response relationship in tuberculosis treatment: why are we still in the dark and how can we get out?

van den Boogaard J, Boeree MJ, Kibiki GS, Aarnoutse RE.

Trop Med Int Health. 2011 Jun;16(6):693-8. doi: 10.1111/j.1365-3156.2011.02755.x.

2.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
3.

Multi-drug resistant tuberculosis burden and risk factors: an update.

Marahatta SB.

Kathmandu Univ Med J (KUMJ). 2010 Jan-Mar;8(29):116-25. Review.

PMID:
21209520
4.

'Sputnik': a programmatic approach to improve tuberculosis treatment adherence and outcome among defaulters.

Gelmanova IY, Taran DV, Mishustin SP, Golubkov AA, Solovyova AV, Keshavjee S.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1373-9. doi: 10.5588/ijtld.10.0531.

PMID:
22283898
5.

Effect of pharmacist-led patient education on adherence to tuberculosis treatment.

Clark PM, Karagoz T, Apikoglu-Rabus S, Izzettin FV.

Am J Health Syst Pharm. 2007 Mar 1;64(5):497-505.

PMID:
17322163
6.

Directly observed treatment is associated with reduced default among foreign tuberculosis patients in Thailand.

Kapella BK, Anuwatnonthakate A, Komsakorn S, Moolphate S, Charusuntonsri P, Limsomboon P, Wattanaamornkiat W, Nateniyom S, Varma JK.

Int J Tuberc Lung Dis. 2009 Feb;13(2):232-7.

PMID:
19146753
7.

Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?

Di Perri G, Bonora S.

J Antimicrob Chemother. 2004 Sep;54(3):593-602. Review.

8.

Clinical tuberculosis and treatment outcomes.

Jordan TS, Davies PD.

Int J Tuberc Lung Dis. 2010 Jun;14(6):683-8. Review.

PMID:
20487604
9.
10.

Infection caused by Mycobacterium tuberculosis.

Peloquin CA, Berning SE.

Ann Pharmacother. 1994 Jan;28(1):72-84. Review.

PMID:
8123968
11.

Experiences of a community-based tuberculosis treatment programme in Namibia: a comparative cohort study.

Zvavamwe Z, Ehlers VJ.

Int J Nurs Stud. 2009 Mar;46(3):302-9. doi: 10.1016/j.ijnurstu.2008.09.013.

PMID:
18995854
12.

Biomarkers for TB treatment response: challenges and future strategies.

Walzl G, Ronacher K, Djoba Siawaya JF, Dockrell HM.

J Infect. 2008 Aug;57(2):103-9. doi: 10.1016/j.jinf.2008.06.007. Review.

PMID:
18649943
13.

Predictors and mortality associated with treatment default in pulmonary tuberculosis.

Kliiman K, Altraja A.

Int J Tuberc Lung Dis. 2010 Apr;14(4):454-63.

PMID:
20202304
14.

Lay health worker-supported tuberculosis treatment adherence in South Africa: an interrupted time-series study.

Atkins S, Lewin S, Jordaan E, Thorson A.

Int J Tuberc Lung Dis. 2011 Jan;15(1):84-9, i.

PMID:
21276302
15.

Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase.

Manders AJ, Banerjee A, van den Borne HW, Harries AD, Kok GJ, Salaniponi FM.

Int J Tuberc Lung Dis. 2001 Sep;5(9):838-42.

PMID:
11573895
16.
17.

[Factors associated with tuberculosis treatment non-compliance in Antananarivo city, Madagascar].

Rakotonirina el-CJ, Ravaoarisoa L, Randriatsarafara FM, Rakotomanga Jde D, Robert A.

Sante Publique. 2009 Mar-Apr;21(2):139-46. doi: 10.3917/spub.092.0139. French.

PMID:
19476664
18.

Multilevel factors affecting tuberculosis diagnosis and initial treatment.

Thongraung W, Chongsuvivatwong V, Pungrassamee P.

J Eval Clin Pract. 2008 Jun;14(3):378-84. doi: 10.1111/j.1365-2753.2007.00871.x.

PMID:
18373583
19.

Factors influencing non-adherence to tuberculosis treatment in Jepara, central Java, Indonesia.

Rondags A, Himawan AB, Metsemakers JF, Kristina TN.

Southeast Asian J Trop Med Public Health. 2014 Jul;45(4):859-68.

PMID:
25427354
Items per page

Supplemental Content

Support Center